Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...

Oral Hypoglycemic Agents: Biguanides and Glitazones

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Hyperglycemia

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pearls.

The Physician and sportsmedicine·2017

Same author

Pearls.

The Physician and sportsmedicine·2017

Same author

Attention deficit hyperactivity disorder and athletes.

Sports health·2014

Same author

Diabetes in the competitive athlete.

Current sports medicine reports·2012

Same author

Attention deficit hyperactivity disorder and the athlete: an American Medical Society for Sports Medicine position statement.

Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine·2011

Same author

Good laboratory practices and safety assessments.

Environmental health perspectives·2010

Search research articles

Related Experiment Video

Updated: May 23, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Patient empowerment and optimal glycemic control.

Russell D White¹

¹Department of Community and Family Medicine, University of Missouri–Kansas City, School of Medicine, Truman Medical Center Lakewood, 7900 Lee’s Summit Road, Kansas City, Missouri 64139, USA. jockdoc2000@hotmail.com

Current Medical Research and Opinion

|March 21, 2012

Summary

Empowering type 2 diabetes patients with knowledge and effective insulin use strategies improves glycemic control and slows disease progression. Interactive education and insulin titration algorithms enhance self-management and patient outcomes.

Related Experiment Videos

Last Updated: May 23, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Area of Science:

Endocrinology
Diabetes Management
Patient Education

Background:

Type 2 diabetes mellitus (T2DM) management requires effective insulin use and patient self-care.
Clinicians need updated strategies for insulin therapy and patient education.
Current approaches often focus on medical information without guaranteed patient empowerment.

Purpose of the Study:

To review strategies for insulin use in T2DM.
To explore educational approaches that empower patients in self-management.
To update clinicians on best practices for insulin therapy and patient education.

Main Methods:

PubMed literature search for peer-reviewed clinical trials in the last 10 years.
Keywords included 'glycemic control', 'insulin', 'type 2 diabetes', 'patient empowerment', and 'self-management'.
12 clinical trials were selected based on relevance, methodology, results, and clinical implications.

Main Results:

Patient empowerment through knowledge facilitates active participation in diabetes care.
Effective educational strategies include interactive teaching, problem-solving, and individualized education.
Insulin titration algorithms are user-friendly tools that empower patients using insulin analogs.

Conclusions:

Empowered T2DM patients are more likely to achieve blood glucose and A1C goals.
Patient education and self-management strategies can slow disease progression and reduce complications.
Physician roles evolve to advisors, supporting empowered patients in managing their T2DM therapy.